BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koszewicz M, Jaroch J, Brzecka A, Ejma M, Budrewicz S, Mikhaleva LM, Muresanu C, Schield P, Somasundaram SG, Kirkland CE, Avila-Rodriguez M, Aliev G. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Pharmacol Res 2021;164:105277. [PMID: 33166735 DOI: 10.1016/j.phrs.2020.105277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Ma C, Hurilebagen, Yuan H, Hu R, Wang W, Weilisi. Effects of lactoferrin on intestinal flora of metabolic disorder mice. BMC Microbiol 2022;22. [DOI: 10.1186/s12866-022-02588-w] [Reference Citation Analysis]
2 Ghadiri F, Ebadi Z, Asadollahzadeh E, Naser Moghadasi A. Gut microbiome in multiple sclerosis-related cognitive impairment. Mult Scler Relat Disord 2022;67:104165. [PMID: 36152393 DOI: 10.1016/j.msard.2022.104165] [Reference Citation Analysis]
3 Chen X, Gu M, Hong Y, Duan R, Zhou J. Association of Trimethylamine N-Oxide with Normal Aging and Neurocognitive Disorders: A Narrative Review. Brain Sciences 2022;12:1203. [DOI: 10.3390/brainsci12091203] [Reference Citation Analysis]
4 Bao Z, Zhang Z, Zhou G, Zhang A, Shao A, Zhou F. Novel Mechanisms and Therapeutic Targets for Ischemic Stroke: A Focus on Gut Microbiota. Front Cell Neurosci 2022;16:871720. [DOI: 10.3389/fncel.2022.871720] [Reference Citation Analysis]
5 Machida K, Tahara SM. Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells. Cancers (Basel) 2022;14:2381. [PMID: 35625986 DOI: 10.3390/cancers14102381] [Reference Citation Analysis]
6 Chidambaram SB, Rathipriya AG, Mahalakshmi AM, Sharma S, Hediyal TA, Ray B, Sunanda T, Rungratanawanich W, Kashyap RS, Qoronfleh MW, Essa MM, Song BJ, Monaghan TM. The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke. Cells 2022;11:1239. [PMID: 35406804 DOI: 10.3390/cells11071239] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
7 Cantero M, Guedes M, Fernandes R, Lollo PCB. Trimethylamine N-oxide reduction is related to probiotic strain specificity: a systematic review. Nutrition Research 2022. [DOI: 10.1016/j.nutres.2022.04.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zheng Y, Liu Y, Wu J, Xie Y, Yang S, Li W, Sun H, He Q, Wu T. Predicted Cognitive Conversion in Guiding Early Decision-Tailoring on Patients With Cognitive Impairment. Front Aging Neurosci 2022;13:813923. [DOI: 10.3389/fnagi.2021.813923] [Reference Citation Analysis]
9 Dang Y, Zhang X, Zheng Y, Yu B, Pan D, Jiang X, Yan C, Yu Q, Lu X. Distinctive Gut Microbiota Alteration Is Associated with Poststroke Functional Recovery: Results from a Prospective Cohort Study. Neural Plast 2021;2021:1469339. [PMID: 34917142 DOI: 10.1155/2021/1469339] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Aragón-Vela J, Solis-Urra P, Ruiz-Ojeda FJ, Álvarez-Mercado AI, Olivares-Arancibia J, Plaza-Diaz J. Impact of Exercise on Gut Microbiota in Obesity. Nutrients 2021;13:3999. [PMID: 34836254 DOI: 10.3390/nu13113999] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Saji N, Tsuduki T, Murotani K, Hisada T, Sugimoto T, Kimura A, Niida S, Toba K, Sakurai T. Relationship between the Japanese-style diet, gut microbiota, and dementia: A cross-sectional study. Nutrition 2021;94:111524. [PMID: 34952361 DOI: 10.1016/j.nut.2021.111524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
12 Zhang W, Zhang X, Zhang Y, Wu H, Liu Q, Zhou X, Meng Y. Analysis of Changes of Intestinal Flora in Elderly Patients with Alzheimer's Disease and Liver Cancer and Its Correlation with Abnormal Gastrointestinal Motility. J Oncol 2021;2021:7517379. [PMID: 34422052 DOI: 10.1155/2021/7517379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Mol Med Rep 2021;24:734. [PMID: 34414447 DOI: 10.3892/mmr.2021.12374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Dos Santos Ramos A, Viana GCS, de Macedo Brigido M, Almeida JF. Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets. Pharmacol Res 2021;171:105779. [PMID: 34298111 DOI: 10.1016/j.phrs.2021.105779] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Giovannini MG, Lana D, Traini C, Vannucchi MG. The Microbiota-Gut-Brain Axis and Alzheimer Disease. From Dysbiosis to Neurodegeneration: Focus on the Central Nervous System Glial Cells. J Clin Med 2021;10:2358. [PMID: 34072107 DOI: 10.3390/jcm10112358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lv M, Gao F, Liu B, Pandey P, Feng Y, Wang Y, Zhang Y, Li Z. The Effects of Obesity on Mortality Following Coronary Artery Bypass Graft Surgery: A Retrospective Study from a Single Center in China. Med Sci Monit 2021;27:e929912. [PMID: 33903583 DOI: 10.12659/MSM.929912] [Cited by in F6Publishing: 1] [Reference Citation Analysis]